Intellia Therapeutics (NTLA) Tax Rate (2015)
Intellia Therapeutics (NTLA) posted quarterly Tax Rate of 4.48% for Q4 2015, down 47.56% quarter-over-quarter from 8.54% in Q3 2015.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Tax Rate (2015) Analysis & Trends
Intellia Therapeutics (NTLA) has reported Tax Rate for 1 consecutive years, with 4.48% the latest figure, recorded in Q4 2015.
- In Q4 2015, Tax Rate changed N/A year-over-year to 4.48%; the TTM figure through Sep 2016 stood at 0.93% (changed N/A YoY), while the FY2015 annual figure was 7.55%, changed N/A from the prior year.
- Tax Rate declined to 4.48% in Q4 2015 per NTLA's latest filing, from 8.54% in the prior quarter.
- Across five years, Tax Rate topped out at 11.16% in Q2 2015 and bottomed at 4.48% in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Intellia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 4.48% |
| Sep 30, 2015 | 8.54% |
| Jun 30, 2015 | 11.16% |
| Mar 31, 2015 | 8.54% |